CORVALLIS, Ore. – A higher intake of vitamin C is crucial for metabolic syndrome patients trying to halt a potentially deadly cycle of antioxidant disruption and health-related problems, an Oregon State University researcher says. That’s important news for the estimated 35 percent of the U.S. adult population that suffers from the syndrome. “What these findings...
Year: <span>2019</span>
Post
Allergies and Depression: The Surprising Connection
Are allergies and depression or anxiety related? Allergy symptoms include sneezing, a runny nose, coughing, a sore throat, and a headache. These symptoms range from mild to severe. While some people with allergies can go about their normal daily routine in only slight discomfort, others might feel physically ill. CONNECTIONS: If you have depression and anxiety along with allergies, you might think the former conditions...
Post
Stem cell shots linked to bacterial infection outbreak
Health officials on Thursday reported an outbreak of bacterial infections in people who got injections of stems cells derived from umbilical cord blood. In this Oct. 22, 2008 file photo, a researcher examines human embryonic stem cells with a microscope in Michigan. On Thursday, Dec. 20, 2018, the Centers for Disease Control and Prevention reported that at...
Post
Certain antibiotics may cause aortic aneurysm, FDA warns
(CNN)The US Food and Drug Administration warned on Thursday that the benefits of fluoroquinolone antibiotics do not outweigh the risks — which include aortic aneurysm — for certain patients, according to the latest research. The research is based on reports of patient problems and on studies published between 2015 and 2018. Fluoroquinolone antibiotics are often...
Post
Blood pressure medication recalled due to ‘unexpected impurity’
According to the FDA (United States Food and Drug Administration), Torrent Pharmaceuticals Limited is voluntarily recalling two lots of Losartan potassium tablets, (FDA) (WBTV) – A pharmaceutical company has issued a voluntary recall of blood pressure medicationThursday. According to the FDA (United States Food and Drug Administration), Torrent Pharmaceuticals Limited is voluntarily recalling two lots of Losartan potassium tablets,...
Post
Cholesterol-lowering drugs reduce brown adipose tissue
A certain proportion of the adult population has not only white adipose (or fatty) tissue, but also the brown kind. This brown adipose tissue helps to convert sugar and fat into heat. People with brown adipose tissue are better at regulating their body temperature in the winter, and are less likely to suffer from excess...
Post
Statins are more effective for those who follow the Mediterranean diet
A diet based on Mediterranean principles enhances the effect of these drugs in patients who already had a heart attack or stroke ISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED I.R.C.C.S. For those who have already had a heart attack or a stroke, the combination of statins and Mediterranean Diet appears to be the most effective choice to reduce the risk of mortality,...
Post
FDA casts shadow on hemp win, calling CBD products illegal
The hemp industry still has work ahead to win legal status for hemp-derived cannabidiol, or CBD oil, as an ingredient in food or dietary supplements despite the big farm bill President Donald Trump signed this week designating hemp as an agricultural crop. CBD oils have become increasingly popular in lotions, tinctures and foods, but their...
Post
Two Commonly Prescribed Type 2 Diabetes Drugs Raise Risk For Heart Attack
Two drugs that doctors commonly prescribe for patients with type 2 diabetes carry an increased risk of cardiovascular events such as stroke, heart attack, heart failure, and even amputation. Sulfonylureas And Basal Insulin Matthew O’Brien, from Northwestern University Feinberg School of Medicine, warned diabetes patients to be aware of medications they take in case these could lead...
Post
FDA approves drugs for treatment of two rare blood diseases
(HealthDay)—Two drugs have been approved by the U.S. Food and Drug Administration for the treatment of rare blood diseases, the agency announced Friday. Elzonris (tagraxofusp-erzs) infusion was granted the first approval for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and children aged 2 years and older. Researchers investigated the efficacy of...